Duchenne muscular dystrophy (DMD): female carriers
Evidence-based neurology checklist on duchenne muscular dystrophy (dmd): female carriers: Phenotypes Asymptomatic Muscle weakness: mild or moderate Muscle pain Cramps X-linked dilated cardiomyopathy (XLDCM) Raised creatinine kinase (CK) Blood tests Molecular analysis Management
Phenotypes
- Asymptomatic
- Muscle weakness: mild or moderate
- Muscle pain
- Cramps
- X-linked dilated cardiomyopathy (XLDCM)
- Raised creatinine kinase (CK)
Blood tests
Molecular analysis
Management
References
- American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Paediatrics 2005; 116:1569-1573.
- Soltanzadeh P, Friez MJ, Dunn D, et al. Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord 2010; 20:499-504.
- Hoogerwaard EM, Bakker E, Ippel PF, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 1999; 353:2116–2119.
- Ceulemans BP, Storm K, Reyniers E, Jr, Callewaert L, Martin JJ. Muscle pain as the only presenting symptom in a girl with dystrophinopathy. Pediatr Neurol 2008; 38:64–66.
- Manzur AY, Kinali M, Muntoni F. Update on the management of Duchenne muscular dystrophy. Arch Dis Child 2008; 93:986-990.
- And 6 more. Subscribe to see the full list
Related checklists
- Duchenne muscular dystrophy (DMD): clinical features
- Duchenne muscular dystrophy (DMD): investigations
- Duchenne muscular dystrophy (DMD): bone health management
- Duchenne muscular dystrophy (DMD): respiratory management
- Duchenne muscular dystrophy (DMD): cardiac management
- Duchenne muscular dystrophy (DMD): genetic treatments
- Duchenne muscular dystrophy (DMD): steroid management
- Duchenne muscular dystrophy (DMD): other treatments
- Duchenne muscular dystrophy (DMD): investigational treatments